320 filings
Page 3 of 16
8-K
u2y2fu71r9t m3u
23 Nov 22
Entry into a Material Definitive Agreement
5:23pm
8-K
z2ypm
18 Oct 22
Entry into a Material Definitive Agreement
5:44pm
8-K
fodghtt m4
3 Oct 22
Changes in Registrant's Certifying Accountant
5:14pm
DEFA14A
742uv8zor d3o
1 Sep 22
Additional proxy soliciting materials
4:00pm
DEFM14A
8z020tie
31 Aug 22
Proxy related to merger
5:19pm
PREM14A
4w152 t6aegcy
15 Aug 22
Preliminary proxy related to merger
12:00am
8-K
x2x p3srn
20 Jul 22
Entry into a Material Definitive Agreement
7:01pm
8-K
kt3d v3no
17 Jun 22
Entry into a Material Definitive Agreement
5:22pm
8-K
thaey
23 May 22
Entry into a Material Definitive Agreement
5:05pm
8-K
boj5wj9e16u
12 May 22
Skye Bioscience Signs Arrangement Agreement with Emerald Health Therapeutics
9:08am
8-K
rt1eav845y9ikcu
20 Dec 21
Skye Bioscience Announces Promotion of Tu Diep, MSc to Chief Development Officer
5:25pm
424B3
wscl pd5u7jatbk59y
10 Nov 21
Prospectus supplement
8:57am
8-K
w6735zdphkku aq
15 Oct 21
Entry into a Material Definitive Agreement
5:05pm
8-K
ln7g5xrgmg
6 Oct 21
Skye Bioscience Appoints Kaitlyn Arsenault as Chief Financial Officer
12:00am
8-K
dzaua x4jeiy1e
30 Sep 21
Skye Bioscience Announces Closing of $7.0 Million Registered Direct Offering
12:00am